GlassScriptPhysician profile
Jackline Shawki
NPI 1841613569
$2,905.04
in general payments reported to CMS, 2019-2025
15 companies · $1,046 in 2025
The $1,046 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $17.87 · 2021: $75.57 · 2022: $247 · 2023: $722 · 2024: $512 · 2025: $1,046.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,241 · Entertainment: $39.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,240.54 |
| Entertainment | $39.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $688.73 | 2022-2025 | Acuvue |
| Lumenis Be INC | $600.00 | 2025 | Optilight |
| Alcon Vision LLC | $387.78 | 2022-2025 | Clareon, Total30, Precision 1 |
| Sight Sciences, INC. | $216.55 | 2019-2024 | Tearcare System |
| Dompe US, INC. | $180.00 | 2023-2025 | Oxervate |
| Biotissue Holdings INC. | $169.03 | 2023-2024 | |
| Bausch & Lomb Americas INC. | $149.02 | 2022-2025 | Infuse, Miebo, Xiidra |
| Abbvie INC. | $140.26 | 2023 | Durysta |
| Coopervision INC. | $136.71 | 2019-2023 | Misight Contact Lens |
| Glaukos Corporation | $75.57 | 2021 | |
| Sun Pharmaceutical Industries INC. | $63.19 | 2023 | Cequa |
| Optos, INC. | $39.87 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $27.94 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.49 | 2023 | |
| Oyster Point Pharma, INC. | $14.90 | 2023 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jackline Shawki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.